Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Roche makes and sells medicines and diagnostic tests that help treat and detect diseases like cancer.
Roche is a Swiss healthcare giant with two big, separate businesses: pharmaceuticals and diagnostics. The drug side, which brings in roughly three-quarters of sales, makes medicines for cancer, immune diseases, and disorders of the nervous system. The diagnostics side sells the machines and chemical tests that hospitals and labs use to figure out what is wrong with a patient. Think of it as a company that both writes the treatment and builds the test that tells you which treatment to use. Its customers are hospitals, clinics, doctors, and health insurers, mostly paying through national health systems or insurers rather than out of pocket. It sits in Basel, Switzerland, but earns money all over the world, especially in the United States.
The drug business is the money engine, and a handful of blockbuster cancer medicines do much of the heavy lifting. Roche's big bet for the future is a new generation of drugs, and it has been spending heavily on research and buying smaller biotech firms to refill its pipeline as older medicines face cheaper copycat competition. On the diagnostics side, Roche is one of the world's largest makers of lab tests, spanning everything from routine blood work to sophisticated genetic testing that helps match a patient to the right cancer drug. That testing business became a household name during the pandemic, when it sold huge volumes of COVID-19 tests, though that revenue has since faded back to normal. Roche was founded in 1896 in Basel and has stayed independent and family-influenced for well over a century, which gives it a long-term, steady style. It throws off a lot of cash, and it uses that cash to fund its own research, buy promising companies, and pay a reliable dividend to shareholders — one of the most dependable payouts in Europe. The simple version: Roche sells the tests that find disease and the drugs that treat it, and because both are hard to copy and often paid for by insurers, it earns fat, steady profits it can plow right back into finding the next big cure.
Saved answer · last researched 15 Oct 2026
see a list of the most recent 300 searches below: